Compounds > prednisone

Page last updated: 2024-08-17

prednisone and perphenazine

prednisone has been researched along with perphenazine in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (21.43)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (57.14)	29.6817
2010's	3 (21.43)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Duffy, EM; Jorgensen, WL	1
Topliss, JG; Yoshida, F	1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY	1
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Carrupt, PA; Martel, S; Ottaviani, G	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
SETTEL, E	1
RUDOLPH, BM; RUDOLPH, JA	1
GRATER, WC	1
Gaytán-Martínez, LA; Pérez-Gómez, HR; Ramos-Zúñiga, R; Rochín-Mozqueda, A; Soto-Rodríguez, S; Vega-Ruiz, B	1

Reviews

1 review(s) available for prednisone and perphenazine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

13 other study(ies) available for prednisone and perphenazine

Article	Year
Prediction of drug solubility from Monte Carlo simulations. Bioorganic & medicinal chemistry letters, 2000, Jun-05, Volume: 10, Issue:11 Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility	2000
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics. Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5 Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution	2004
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability. Journal of medicinal chemistry, 2004, Mar-25, Volume: 47, Issue:7 Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties	2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities. Journal of medicinal chemistry, 2007, Feb-22, Volume: 50, Issue:4 Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Treatment of acute and chronic arthralgias with a tranquilizing agent (trilafon) in addition to prednisone or prednisolone. Journal of the American Geriatrics Society, 1958, Volume: 8, Issue:10 Topics: Arthralgia; Hypnotics and Sedatives; Perphenazine; Phenothiazines; Prednisolone; Prednisone; Tranquilizing Agents	1958
Trilafon (perphenazine) and meticorten (prednisone) as ancillary therapy in allergic conditions. The Journal of the Florida Medical Association. Florida Medical Association, 1959, Volume: 45, Issue:9 Topics: Hypersensitivity; Immune System Diseases; Perphenazine; Phenothiazines; Prednisone	1959
Combined steroid-ataractic therapy in allergy. International record of medicine, 1959, Volume: 172 Topics: Hypersensitivity; Immune System Diseases; Perphenazine; Prednisone; Psychotherapy, Multiple; Tranquilizing Agents	1959
[Temporal lobe epilepsy and active neurocysticercosis: two representative case reports]. Revista de neurologia, 2015, Jan-01, Volume: 60, Issue:1 Topics: Albendazole; Anomia; Anthelmintics; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Citalopram; Delayed Diagnosis; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Headache; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurocysticercosis; Oxcarbazepine; Panic Disorder; Perphenazine; Prednisone	2015